Last Price$8.511.2%
Market Cap$1,347.5M
9.2%
Industry median - 3.6%
5Y Historical average - 120.6%
108.5%
Industry median - 8.2%
5Y Historical average - 13.9%
16.0%
Industry median - (12.5%)
5Y Historical average - 53.9%
91.1%
Industry median - 10.8%
5Y Historical average - 11.7%
OCUL Growth Rating
OCUL Growth rating
6.5
OCUL Growth rating performance
OCUL Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with OCUL Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$1,347.5M | 6.5 | 72.0% | 9.2% | 11.7% | (8.1%) | 16.0% | (0.5%) | 11.2% | 91.1% | |
$124.8B | 6.9 | 21.5% | 11.5% | 8.6% | N/A | N/A | (962.4%) | N/A | N/A | |
$77.0B | 5.6 | 12.6% | 8.3% | 2.4% | 16.1% | 10.3% | 3.1% | 12.5% | (5.7%) | |
$34.4B | 6.3 | 106.9% | 127.3% | 76.3% | (9.7%) | (57.5%) | (132.2%) | N/A | (70.8%) | |
$30.7B | 5.4 | 59.2% | 23.0% | 28.6% | (23.2%) | (38.5%) | (26.5%) | (36.7%) | N/A | |
$24.0B | 6.2 | 90.9% | (28.0%) | (28.0%) | 36.5% | N/A | (182.9%) | (3.1%) | N/A | |
$14.5B | 4.0 | 4.5% | (3.8%) | 35.4% | (19.0%) | (9.0%) | 144.6% | 10.7% | (7.3%) | |
$13.8B | 7.5 | 14.7% | 23.6% | 9.1% | N/A | 25.6% | 6.8% | N/A | 44.5% | |
$13.4B | 7.1 | 10.8% | 17.8% | 10.0% | N/A | 152.8% | 48.9% | N/A | 820.5% | |
$13.3B | 6.1 | (100.0%) | N/A | N/A | (0.9%) | (92.8%) | 11.4% | 44.6% | 84.8% | |
$1,846.9M | 5.9 | 50.5% | 50.5% | 50.7% | 25.3% | 20.9% | (35.6%) | 3.3% | (43.8%) |
FAQ
What is the Ocular Therapeutix, Inc. (OCUL) revenue growth?
The Ocular Therapeutix, Inc. (OCUL) revenue growth is 9.2%, which is lower than the industry median of 3.6% and the 5-year historical average of 120.6%.
What is the Ocular Therapeutix, Inc. (OCUL) operating income growth?
The Ocular Therapeutix, Inc. (OCUL) operating income growth is 108.5%, compared to the industry median of 8.2% and the 5-year historical average of 13.9%.
What is the Ocular Therapeutix, Inc. (OCUL) EPS (Earnings Per Share) growth?
The Ocular Therapeutix, Inc. (OCUL) EPS growth is 16.0%, compared to the industry median of (12.5%) and the 5-year historical average of 53.9%.
What is the Ocular Therapeutix, Inc. (OCUL) Free Cash Flow (FCF) growth?
The Ocular Therapeutix, Inc. (OCUL) Free Cash Flow growth is 91.1%, compared to the industry median of 10.8% and the 5-year historical average of 11.7%.